MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

TORONTO, June 24, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce it successfully completed its first export shipment of medical cannabis concentrate into Australia to AusCann Group Holdings Ltd. Through its
[Read More ...]

from
https://www.newcannabisventures.com/medipharm-labs-receives-permits-and-ships-first-medical-cannabis-concentrate-to-australia/